Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

NobelGuard™ - [Screening test for genetic disorder related with development disabilities]

Screen test of the risks through gene analysis for genetic developmental disorders. Enhancing possibility of prevention and improvement of disease by early detection of hereditary diseases. 

Characteristics of NobelGuard™

One-stop examination of a total of 52 orphan diseases (i.e., congenital hearing loss, development disability, and etc.) including metabolism disorder which was impossible with previous methods. 

Mutations identified unprecedentedly by scrutinizing the DNA sequence, based on NGS technology.

Indication of NobelGuard™ (52 diseases)

Metabolism error: 23 diseases

Muscle nerve and skeleton disorder: 13 diseases

Congenital hearing loss: 8 diseases

X-linked intellectual and development disability: 8 diseases